2024 (77 POSTS)
Bates CA, Vincent MJ , Buerger AN , Santamaria AB, Maier A, Jack M. 2024. Investigating the relationship between β-carotene intake from diet and supplements, smoking, and lung cancer risk. Food Chem Toxicol 194:115104; doi: 10.1016/j.fct.2024.115104 . PMID: 39522798.
View Abstract
Topics: Cancer , Food science
Haber LT, Bradley MA, Buerger AN , Behrsing H, Burla S, Clapp PW, et al. 2024. New approach methodologies (NAMs) for the in vitro assessment of cleaning products for respiratory irritation: Workshop report. Front Toxicol 6:1431790; doi: 10.3389/ftox.2024.1431790 . PMID: 39439531.
View Abstract
Topics: NAMs
Mattes RD, Rivera BN, Rutigliani GR, Rogers S , Mendoza ID, Wang L, Beckemeier K, Wikoff D . 2024. A review of low- and no-calorie sweetener safety and weight management efficacy. Nutrition Today 59(6):261-288; doi: 10.1097/NT.0000000000000723 .
View Abstract
Topics: Food science , nutrition , risk assessment
Madl AK, Donnell MT, Covell LT . 2024. Synthetic vitreous fibers (SVFs): Adverse outcome pathways (AOPs) and considerations for next generation new approach methods (NAMs). Crit Rev Toxicol 54(10:754-804; doi: 10.1080/10408444.2024.2390020 . PMID: 39287182.
View Abstract
Topics: Cancer
O’Brien J, Mitchell C, Auerbach S, Doonan L, Ewald J, Everett L, Faranda A, Johnson K, Reardon A, Rooney J., Wheeler MW , et al. 2024. Bioinformatic workflows for deriving transcriptomic points of departure: Current status, data gaps, and research priorities. Toxicol Sci 203(2):147-159; doi: 10.1093/toxsci/kfae145 . PMCID: PMC11775421.
View Abstract
Topics: transcriptomics
Banerjee A, Kar S, Roy K, Patlewicz G , Charest N, Benfenati E, Cronin MTD. 2024. Molecular similarity in chemical informatics and predictive toxicity modeling: From quantitative read-across (q-RA) to quantitative read-across structure-activity relationship (q-RASAR) with the application of machine learning. Crit Rev Toxicol 54(9):659-684; doi: 10.1080/10408444.2024.2386260 . PMID: 39225123.
View Abstract
Topics: modeling
Farris DP, Lebo RA, Price C. 2024. Designing a framework for curriculum building in systematic review competencies for librarians: A case report. J Med Libr Assoc 4:357–363; doi: 10.5195/jmla.2024.1930 .
View Abstract
Topics: Systematic Review
Seo S, Healey BE, McLin R, Sacks NC , Benson CJ, Citrome L. 2024. Impact of demographics and insurance coverage on schizophrenia treatment and healthcare resource utilization within an integrated healthcare system. Neuropsychiatr Dis Treat 20(Sept 26):1837–1848; doi: 10.2147/NDT.S473492 . PMID: 39351585.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
DiBiase JF, Scharnetzki E, Edelman E, Reed EK, Helbig P, Rueter J, Miesfeldt S, Frankenfeld CL , et al. 2024. Socioeconomic and urban-rural disparities in genome-matched treatment receipt and survival after genomic tumor testing. JNCI Cancer Spectr 8(5):pkae090; doi: 10.1093/jncics/pkae090 . PMID: 39312685.
View Abstract
Topics: Cancer , Epidemiology , Health Economics and Outcomes Research (HEOR)
Wilson KP, Valazza E, Price C. 2024. Video modeling to support social communication goals of autistic adults: A tutorial. Am J Speech Lang Pathol 33(5):2249–2265; doi: 10.1044/2024_AJSLP-23-00479 .
View Abstract
Topics: evidence-based reviews , modeling
Monticello TM , Potter DM, Huang Q, Hart TK, Shuey D, Troth S, Vergis JM, Tassew N, et al. 2024. Do longer duration nonclinical toxicology studies provide predictive clinical safety value? The IQ Consortium longer duration nonclinical to clinical translational database. Toxicol Appl Pharmacol 492(Sept 5):117087; doi: 10.1016/j.taap.2024.117087 .
View Abstract
Topics: nonclinical safety assessment
Perry CS , Verwiel AH , Covington TR , Proctor DM . 2024. PBPK modeling demonstrates that exposure time adjustment is unnecessary for setting an acute manganese inhalation exposure guideline. Regul Toxicol Pharmacol 153(Nov):105698; doi: 10.1016/j.yrtph.2024.105698 . PMID: 39251127.
View Abstract
Topics: Air Quality , Manganese , modeling , PBPK/PBDE
Patlewicz G , Judson RS, Williams AJ, Butler T, Barone Jr. S, Carstens K, Cowden J, Dawson JD, et al. 2024. Development of chemical categories for per- and polyfluoroalkyl substances (PFAS) and the proof-of-concept approach to the identification of potential candidates for tiered toxicological testing and human health assessment. Comput Toxicol 131(Sep 1):100327; doi: 10.1016/j.comtox.2024.100327 . PMID: 40547594.
View Abstract
Topics: PFAS
Reynolds JI , Choi J, Johnson BP. 2024. Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation. Curr Res Toxicol 7(Aug 8):100191; doi: 10.1016/j.crtox.2024.100191 . PMID: 39205829.
View Abstract
Topics: Adverse outcome pathways (AOPs) , risk assessment
Barker TH, McBride GM, Dias M, Price C , Munn Z. 2024. Contextual factors and G6PD diagnostic testing: A scoping review and evidence and gap map. Malaria J 23(1):241; doi: 10.1186/s12936-024-05050-6 .
View Abstract
Topics: malaria , scoping review
Jackson JW, Frederick C Streich Jr, Pal A, Coricor G, Boston C, …, Wood M , et al. 2024. An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Sci Signal 17(844):eadn6052; doi: 10.1126/scisignal.adn6052 . PMID: 38980922.
View Abstract
Topics: Toxicology
Pollock D, Bailey HD, Hasanoff S, Munn Z, Valenzuela C, Stern C, Price C, et al . 2024. First Nations Peoples’ perceptions, knowledge and beliefs regarding stillbirth prevention and bereavement practices: A mixed methods systematic review. Women Birth 37(4):101604; doi: 10.1016/j.wombi.2024.101604 .
View Abstract
Topics: Systematic Review
Wingrat J, Price C , Wright T. 2024. Facilitators of and barriers to caregiver adherence to home therapy recommendations for infants and children with neuromotor and neuromuscular diagnoses: A scoping review. Am J Occup Ther 78(5):7805205070; doi: 10.5014/ajot.2024.050567 .
View Abstract
Topics: scoping review
Bean K, Jones SA, Chakrapani A, Vijay S, Wu T, Church H, … Jensen I , et al. 2024. Exploring the cost-effectiveness of newborn screening for metachromatic leukodystrophy (MLD) in the UK. Int J Neonatal Screen 10(3):45; doi: 10.3390/ijns10030045 .
View Abstract